Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Fever and neutropenia in pediatric hematopoietic stem cell transplant patients

Bone Marrow Transplantation volume 25, pages 59–65 (2000)Cite this article

Abstract

The objective of this study was to identify patterns of fever and neutropenia in pediatric patients undergoing initial hospitalization for hematopoietic stem cell transplantation. A retrospective review of 75 HSCTs over a 4-year period at a single institution was performed, of which 68% were allogeneic and 32% were autologous. Stem cell sources included bone marrow (29%), PBSC (52%) and umbilical cord blood (16%). Fever occurred in 74 (98%) of the episodes. Unexplained fever (FUO) occurred in 43%. Bacteremia without an anatomic focus occurred in 29%, while CVC associated infections occurred in 17%. In 49% of transplants at least one blood culture was positive. The incidence of bacteremia was higher in allogeneic HSCTs (58%) than in autologous transplants (29%). Gram-positive bacteria accounted for 71% of the isolates. Lower rates of bacteremia were observed in patients receiving oral fluoroquinolone prophylaxis. The median duration of fever was 12.5 days and time to engraftment 14 days. Regression analysis demonstrated that duration of fever was strongly associated with time to engraftment, and that time to engraftment was associated with source of cells and number of CD34+ cells/kg administered. Recipients of autologous PBSC had the shortest durations of fever and time to engraftment, while recipients of allogeneic umbilical cord blood had the longest. Bone Marrow Transplantation (2000) 25, 59–65.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Rizzo JD . Current trends in BMT ABMTR Newslett 1998 5: 4–10

    Google Scholar 

  2. Chan KW, Petropoulos D, Choroszy M et al. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors Bone Marrow Transplant 1997 20: 1039–1043

    Article  CAS  Google Scholar 

  3. Worth LL, Tran H, Petropoulos D et al. Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan, and cyclophosphamide Bone Marrow Transplant 1999 24: 947–952

    Article  CAS  Google Scholar 

  4. Dell'Orto M, Rovelli A, Barzaghi A et al. Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience Ped Hematol Oncol 1997 14: 335–347

    Article  CAS  Google Scholar 

  5. Salazar R, Solá C, Maroto P et al. Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation BoneMarrow Transplant 1999 23: 27–33

    CAS  Google Scholar 

  6. Kolbe K, Domkin D, Derigs HG et al. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation Bone Marrow Transplant 1997 19: 143–147

    Article  CAS  Google Scholar 

  7. Haahr V, Peterslund NA, Møller JK . The influence of antimicrobial prophylaxis on the microbial and clinical findings in patients after autologous bone marrow transplantation Scand J Infect Dis 1997 29: 623–626

    Article  CAS  Google Scholar 

  8. Mossad SB, Longworth DL, Goormastic M et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients Bone Marrow Transplant 1996 18: 265–271

    CAS  PubMed  Google Scholar 

  9. Lew MA, Kehoe K, Ritz J et al. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial J Clin Oncol 1995 13: 239–250

    Article  CAS  Google Scholar 

  10. Krüger W, Rüssmann B, Kröger N et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation – a 7 year single centre investigation of 409 cases Bone Marrow Transplant 1999 23: 589–597

    Article  Google Scholar 

  11. Schimpff SC . Infections in the cancer patient-diagnosis, prevention, and treatment. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and Practice of Infectious Diseases, 4 edn Churchill Livingstone: New York 1995 pp 2666–2675

    Google Scholar 

  12. Sparrelid E, Remberger M, Ringden O et al. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection Bone Marrow Transplant 1998 22: 795–800

    Article  CAS  Google Scholar 

  13. Ringden O, Remberger M, Lönnqvist B et al. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow Bone Marrow Transplant 1998 22: 131–136

    Article  Google Scholar 

  14. Romano V, Castagnola E, Dallorso S et al. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation Bone Marrow Transplant 1999 23: 271–275

    Article  CAS  Google Scholar 

  15. Rackoff WR, Gonin R, Robinson C et al. Predicting the risk of bacteremia in children with fever and neutropenia J Clin Oncol 1996 14: 919–924

    Article  CAS  Google Scholar 

  16. Lucas KG, Brown AE, Armstrong D et al. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis Cancer 1996 77: 791–798

    Article  CAS  Google Scholar 

  17. Raad II, Whimbey EE, Rolston KVI et al. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients Cancer 1996 77: 1386–1394

    Article  CAS  Google Scholar 

  18. Nosanchuk JD, Sepkowitz KA, Pearse RN et al. Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma Bone Marrow Transplant 1996 18: 355–359

    CAS  PubMed  Google Scholar 

  19. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors New Engl J Med 1998 339: 1565–1577

    Article  CAS  Google Scholar 

  20. Mullen CA, Petropoulos D, Roberts WM et al. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients Cancer 1999 86: 126–134

    Article  CAS  Google Scholar 

  21. Mullen CA, Petropoulos D, Rytting M et al. Acute reversible arthropathy in a pediatric patient with cancer treated with a short course of ciprofloxacin for febrile neutropenia J Ped Hematol Oncol 1998 20: 516–517

    Article  CAS  Google Scholar 

  22. Jick S . Ciprofloxacin safety in a pediatric population Ped Infect Dis J 1997 16: 130–133

    Article  CAS  Google Scholar 

  23. Hampel B, Hullmann R, Schmidt H . Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use–safety report Ped Infect Dis J 1997 16: 127–129

    Article  CAS  Google Scholar 

  24. Hughes WT, Armstrong D, Bodey GP et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America Clin Infect Dis 1997 25: 551–573

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by American Cancer Society Career Development Award CDA-96–61 (CAM).

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    CA Mullen, J Nair, S Sandesh & KW Chan

  2. Department of Experimental Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    CA Mullen

  3. Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    CA Mullen

Authors
  1. CA Mullen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Nair
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Sandesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. KW Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mullen, C., Nair, J., Sandesh, S. et al. Fever and neutropenia in pediatric hematopoietic stem cell transplant patients. Bone Marrow Transplant 25, 59–65 (2000). https://doi.org/10.1038/sj.bmt.1702109

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702109

Keywords

This article is cited by

Search

Advanced search

Quick links